Skip to main content
Clinical Trials/NCT02031029
NCT02031029
Terminated
Not Applicable

A Questionnaire Study by Elevated Prostate Specific Antigen (PSA): Do Men Where Subsequent Assessment Shows Prostate Cancer, Higher Levels of Neuroticism and Stress Compared to Those Who do Not Get the Diagnosis?

Helse Stavanger HF2 sites in 1 country51 target enrollmentDecember 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Prostatic Diseases
Sponsor
Helse Stavanger HF
Enrollment
51
Locations
2
Primary Endpoint
Cholesterol
Status
Terminated
Last Updated
9 years ago

Overview

Brief Summary

It has previously been reported that men with prostate cancer are 1 ) reduced quality of life after diagnosis and treatment, 2 ) neuroticism increases the reduction in QoL related to treatment side effects, and 3) often have very involved and active spouses who seems to have been handed over / taken over parts of the men's responsibility for their own health. We postulate herein a new hypothesis that the stress level is elevated when harbouring undetected prostate cancer. We will investigate whether those who are diagnosed with prostate cancer already in beforehand have an increased degree of masculine stress ( experience of not living up to their own perception of the ideal man ) and neuroticism in the typology. We will examine different personality and QoL questionnaires for patients with elevated PSA, and compare those whose clinical assessment later reveals prostate cancer, with three control groups: 1) men with elevated PSA who are not diagnosed with prostate cancer, 2) men with normal PSA treated for benign prostate enlargement and 3) patient with substantial risk of colorectal cancer (CRC) who undergo colonoscopy, with regard to increased level of masculine stress and the personality trait neuroticism.

Detailed Description

Inclusion criteria: 1. Men who are being referred as new urological outpatient and meet the following criteria: 1. Wanted clinical examined because of elevated PSA 2. Not strong family history of prostate cancer 3. It is taken biopsy as part of routine investigation. 2. Control groups: Men being referred to urological / gastroenterological outpatient clinic, and which meet the following criteria: 1. urination complaints, normal PSA, and study shows prostate size\> 40cc 2. Or melena and cancer suspicion in colorectum 3. Age\> 18 years and \<75 years Outcome measures: Together with statistician look for patterns / covariance in replies from those who are diagnosed with prostate cancer in the questionnaires personality evaluation adapted to normal population (Neo-FFI), gender differentiated stress response questionnaire (MGRSS) and questionnaires related to resilience, relationship and quality of life index, compared with the control groups.

Registry
clinicaltrials.gov
Start Date
December 2013
End Date
December 18, 2015
Last Updated
9 years ago
Study Type
Observational
Sex
Male

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Men who be referred a new urological outpatient and satisfy the following:
  • Wanted examined because of elevated PSA
  • Not strong family history of prostate cancer
  • It is taken biopsy as part of routine investigation.
  • Control group: Men referred to urological outpatient clinic, and who satisfy the following
  • urination complaints
  • Normal PSA
  • examination shows prostate size\> 40cc
  • Control group: Men first time referred urological / gastroenterological outpatient clinic, and which satisfy the following
  • - symptoms that might indicate cancer suspicion in colorectum

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Cholesterol

Time Frame: 2 years

Cholesterol at baseline and 2 years will be related to wether the patient has confirmed cancer or not.

Testosterone

Time Frame: 2 years

Testosterone at baseline and 2 years will be related to wether the patient has confirmed cancer or not.

MGRSS questionnaire

Time Frame: 2 years

The profile of the answering patterns will be compared to baseline using psychiatric and statistical evaluation.

Secondary Outcomes

  • Vitamin D, Folic acid, White Blood Cells, C-reactive protein (CRP)(2 years)
  • coffee and green tea consumption(2 years)

Study Sites (2)

Loading locations...

Similar Trials